ABBV Abbvie Inc

NYSEStockView on Yahoo Finance ↗

$288.78

+2.16% (24h)

Updated 19:10 UTC

3 months: +13.97%Updated 19:10 UTC

Market Cap

$510.31B

24h Volume

$2.95M

1h %

—

7d %

+5.26%

Related News

AbbVie Secures FDA Approval for Parkinson's Drug Juvmo

AbbVie Secures FDA Approval for Parkinson's Drug Juvmo

AbbVie's Immunology Franchise Drives Growth with Skyrizi and Rinvoq

AbbVie's Immunology Franchise Drives Growth with Skyrizi and Rinvoq

AbbVie Drug Atogepant Reduces Menstrual Migraine Days in Phase 3 Trial

AbbVie Drug Atogepant Reduces Menstrual Migraine Days in Phase 3 Trial

AbbVie Shares Decline After 2026 Guidance Cut on Apogee Acquisition

AbbVie Shares Decline After 2026 Guidance Cut on Apogee Acquisition